Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

BACKGROUND: Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials (RCTs) have demonstrated survival benefits of alternative treatments to docetaxel. However, information is lacking on w...

Descripción completa

Detalles Bibliográficos
Autores principales: Vickers, Adrian D., Winfree, Katherine B., Cuyun Carter, Gebra, Kiiskinen, Urpo, Jen, Min-Hua, Stull, Donald, Kaye, James A., Carbone, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466705/
https://www.ncbi.nlm.nih.gov/pubmed/30987609
http://dx.doi.org/10.1186/s12885-019-5569-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466705/
https://www.ncbi.nlm.nih.gov/pubmed/30987609
http://dx.doi.org/10.1186/s12885-019-5569-5

Ejemplares similares